NCT05485077Recruiting
A Prospective Cohort Study on Colorectal Cancer Screening in Community Population
Colorectal Cancer Screening Cohort Study in Shougang Community Population Based on Polygene Methylation Detection Technology
Source: ClinicalTrials.gov · Last updated 17 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will validate the real world results of polygene methylation detection in colorectal cancer in a large prospective community cohort. In this study, questionnaire survey and polygene methylation detection technology of colorectal cancer were used as preliminary screening methods, and colonoscopy was used as further validation examination method to screen colorectal cancer and precancerous lesions. The diagnosis and outcome of all lesions were based on colonoscopy and pathological examination.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 18000 (estimated)
- First submitted
- 26 Jul 2022
- Start date
- 9 Jul 2022
- Primary completion date
- 9 Jul 2028
- Lead sponsor
- Singlera Genomics Inc.
- Diseases
- Colorectal cancer
- NCT number
- NCT05485077
What you commit to
- Study type: Observational
- Planned participants: 18000
- From 9 Jul 2022 to the primary completion date, 9 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous colorectal resection;
- Patients who have received major surgical treatment such as blood transfusion or transplantation within 3 months;
Other illness
- History of colorectal cancer and other malignant tumors;
- undergoing any cancer-related treatment;
- Have autoimmune disease, hereditary disease, mental illness/disability, etc
Other
- Participate in other interventional clinical investigators within 3 months;
- Pregnant or lactating women;
- Poor compliance, unable to complete the study.
Who the study is looking for
- Chronological age ≥40 years;
- Full capacity for action;
- After enrollment, the participants were able to complete the Colorectal Cancer Risk Factor Assessment Questionnaire and the annual follow-up interviews;
- In the course of the study, the information related to tumor diagnosis in other hospitals can be timely fed back to the researchers;
Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University Shougang Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.